TGFB1 and liver disorder: The over-expression of TGF-β1 can induce hepatic fibrosis and eventually end-stage liver disease which supports our findings as TGF-β1 is a significant peptide mediator of hepatic stellate cells (HSC), which activate and stimulate matrix synthesis, leading to progressive liver fibrosis (Dewidar et al., 2019).